Your browser doesn't support javascript.
loading
Combined RAF and MEK Inhibition to Treat Activated Non-V600 BRAF-Altered Advanced Cancers.
Rustgi, Naryan; Maria, Ann; Toumbacaris, Nicolas; Zhao, HuiYong; Kargus, Katherine; Bryant, Morgan; Waksmundzki, Alexandra; Aricescu, Ilinca; Lefkowitz, Robert A; Li, Bob T; Chou, Joanne; Capanu, Marinela; de Stanchina, Elisa; Misale, Sandra; Shia, Jinru; Yaeger, Rona.
Afiliación
  • Rustgi N; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Maria A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Toumbacaris N; Department of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Zhao H; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Kargus K; Department of Nursing, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Bryant M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Waksmundzki A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Aricescu I; Gerstner Sloan Kettering Graduate School of Biomedical Sciences, New York, NY, USA.
  • Lefkowitz RA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Li BT; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Chou J; Department of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Capanu M; Department of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • de Stanchina E; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Misale S; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Shia J; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Yaeger R; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Oncologist ; 29(1): 15-24, 2024 Jan 05.
Article en En | MEDLINE | ID: mdl-37616543
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas B-raf / Melanoma Límite: Humans Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas B-raf / Melanoma Límite: Humans Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido